BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 19590269)

  • 1. Policy decision-making under scientific uncertainty: radiological risk assessment and the role of expert advisory groups.
    Mossman KL
    Health Phys; 2009 Aug; 97(2):101-6. PubMed ID: 19590269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk characterization: A bridge to informed decision making.
    North DW
    Fundam Appl Toxicol; 1997 Oct; 39(2):81-8. PubMed ID: 9344620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the role of science in the decision-making of the European Union.
    Allio L; Ballantine B; Meads R
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):4-13. PubMed ID: 16266777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precaution, uncertainty and causation in environmental decisions.
    Ricci PF; Rice D; Ziagos J; Cox LA
    Environ Int; 2003 Apr; 29(1):1-19. PubMed ID: 12605931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy and science in children's health and environment: recommendations from the PINCHE project.
    van den Hazel P; Zuurbier M; Bistrup ML; Busby C; Fucic A; Koppe JG; Lundqvist C; Ronchetti R; ten Tusscher G
    Acta Paediatr Suppl; 2006 Oct; 95(453):114-9. PubMed ID: 17000578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can research contribute to regulatory decisions about the health risks of multiple chemical sensitivity?
    Dyer RS; Sexton K
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S139-51. PubMed ID: 8921569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do we combine science and regulations for decision making following a terrorist incident involving radioactive materials?
    Poston JW; Ford JR
    Health Phys; 2009 Nov; 97(5):537-41. PubMed ID: 19820465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How much uncertainty is too much and how do we know? A case example of the assessment of ozone monitor network options.
    Stahl CH; Cimorelli AJ
    Risk Anal; 2005 Oct; 25(5):1109-20. PubMed ID: 16297218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late lessons from early warnings: towards precaution and realism in research and policy.
    Gee D; Krayer von Krauss MP
    Water Sci Technol; 2005; 52(6):25-34. PubMed ID: 16304931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science, policy, and the protection of human health: a European perspective.
    Martuzzi M
    Bioelectromagnetics; 2005; Suppl 7():S151-6. PubMed ID: 16059917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Politicizing science: the case of the Bush administration's influence on the lead advisory panel at the Centers for Disease Control.
    Markowitz G; Rosner D
    J Public Health Policy; 2003; 24(2):105-29. PubMed ID: 14601534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing scientific uncertainty in medical decision making: the case of the advisory committee on immunization practices.
    Martinez JM
    J Med Philos; 2012 Feb; 37(1):6-27. PubMed ID: 22198966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European micronutrient recommendations aligned: a general framework developed by EURRECA.
    Dhonukshe-Rutten RA; Timotijevic L; Cavelaars AE; Raats MM; de Wit LS; Doets EL; Tabacchi G; Roman B; Ngo-de la Cruz J; Gurinovic M; de Groot LC; van 't Veer P
    Eur J Clin Nutr; 2010 Jun; 64 Suppl 2():S2-10. PubMed ID: 20517317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.
    Duclos P
    Vaccine; 2010 Apr; 28 Suppl 1():A18-25. PubMed ID: 20412991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The National Bioethics Advisory Commission: bridging the tension between scientific and public policy analysis.
    Charo RA
    J Biolaw Bus; 1998; 1(2):84-9. PubMed ID: 12739543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups.
    Gessner BD; Duclos P; Deroeck D; Nelson EA
    Vaccine; 2010 Apr; 28 Suppl 1():A1-5. PubMed ID: 20412988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation doses and risks from internal emitters.
    Harrison J; Day P
    J Radiol Prot; 2008 Jun; 28(2):137-59. PubMed ID: 18495991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization.
    Ismail SJ; Langley JM; Harris TM; Warshawsky BF; Desai S; FarhangMehr M
    Vaccine; 2010 Apr; 28 Suppl 1():A58-63. PubMed ID: 20412999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drawing the battle lines: tracing the "Science War" in the construction of the chloroform and human health risks debate.
    Driedger SM; Eyles J
    Environ Manage; 2003 Apr; 31(4):476-88. PubMed ID: 12677294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.